Gene therapy is changing how we treat disease
HN Summary • Gene therapy is shifting medicine from treating symptoms to targeting disease at its genetic source, offering new hope for conditions such as Huntington’s disease, sic...
Search fresh public links, source activity, and ready-to-use post angles for Gene Therapy.
Fresh curated links around Gene Therapy are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
HN Summary • Gene therapy is shifting medicine from treating symptoms to targeting disease at its genetic source, offering new hope for conditions such as Huntington’s disease, sic...
A gene therapy aimed at correcting fragile X syndrome by restoring the missing FMR1 protein has demonstrated multiple disease-relevant improvements in a mouse model, according to a...
A new gene therapy has been used to successfully treat a deadly childhood liver disease in mice that model the disease, according to researchers at UCL and Great Ormond Street Hosp...
A 6-year-old boy with Cockayne syndrome — a rare genetic disorder that causes hearing loss, vision impairment, and early death — has become the first child to receive an experiment...
An 8-month-old infant with severe genetic epilepsy has become the first patient in the world to receive an experimental gene replacement therapy designed to restore the function of...
An experimental gene therapy called SynCav1 can protect the central nervous system from the cognitive decline linked to TDP-43-related proteinopathy, a primary driver of FTD, ALS,...
In May 2025, a young boy received an injection delivering a healthy copy of a gene called OTOF into the cochlea of his inner ear — one of the first patients with hereditary hearing...
In a groundbreaking advance poised to reshape gene therapy and molecular medicine, researchers have unveiled a novel strategy for precise gene regulation via RNA splicing modulatio...
In a groundbreaking advancement in the treatment of fragile X syndrome (FXS), researchers have successfully deployed gene therapy targeting the FMR1 gene, restoring key neurologica...
A man is now the first person in Louisiana to be functionally cured of sickle cell disease through gene therapy.
Growing interest in in vivo cell and gene therapies is driving significant investment, given their potential to address some of the manufacturing and commercialization challenges a...
The therapy restored FMRP expression in crucial brain regions, resulting in reduced audiogenic seizure susceptibility, normalized sensory hyperactivity, and complete reversal of el...
A gorilla adenovirus originally developed for vaccines is showing unexpected promise as a cancer therapy—one whose therapeutic properties may be baked into its native biology rathe...
A new treatment for children aged 2 or older with sickle cell disease has been approved by the U.S. Food & Drug Administration.
Learn how gene editing is transforming sickle cell disease treatment and why expanding access to younger children matters.
You might recall that gene therapy to overexpress caveolin-1 in the brain was recently shown to reduce pathology in a mouse model of Alzheimer's disease. In today's open access pap...
A man is now the first person in Louisiana to be functionally cured of sickle cell disease through gene therapy.
In a groundbreaking study that could redefine treatment paradigms for spinal muscular atrophy (SMA), researchers have released a comprehensive long-term comparative analysis of ade...
A new treatment for children aged 2 or older with sickle cell disease has been approved by the U.S. Food & Drug Administration.
As someone who has spent decades peering into skulls and pondering the fragile machinery inside, I have seen firsthand how our gray matter can falter under the weight of time, gene...
A new treatment for children aged 2 or older with sickle cell disease has been approved by the U.S. Food & Drug Administration.
A new treatment platform developed by researchers at the University of Texas MD Anderson Cancer Center was able to deliver messenger RNA (mRNA) of the full-length DMD gene into pre...
An experimental gene-silencing therapy safely lowered LRRK2 protein levels in an early Parkinson’s trial, but its effect on symptoms remains untested. An experimental medicine buil...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.